Skip to main content
OpenTrials
Completed

NCT Number: NCT01706380

3M Study - Maria Malmö Mobile Telephone Study

The present study, in an out-patient setting for substance use treatment in adolescents, examines the effect on treatment retention of a mobile telephone follow-up technique (interactive voice response), with or without personal feedback. Subjects in treatment for substance use disorders will be followed by automated mobile telephone contact with questions about psychiatric symptoms and substance use, and the investigators hypothesize that this technique, including a personal feedback reporting back to the client whether his or her status is changing in one way or another, may increase the treatment retention, possibly by means of an intensified treatment contact.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Substance Use Disorders Chemically-Induced Disorders Mental Disorders Substance-Related Disorders

Age range

Up to 25 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Maria Malmö, Dept of Psychiatry Skane and City of Malmö, Sweden

Malmö, Skåne County, 205 02, Sweden

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient applying for substance use disorder treatment at out-patient facility Maria Malmö, Malmö, Sweden, who are less than 25 years old and who provide written informed consent to participate in the study.

Exclusion criteria

  • Patients who do not provide written informed consent to the study, or whose psychiatric condition or language difficulties make it impossible for them to understand patient information and give informed consent to the study.

Treatment and study plan

Interactive voice response with personal feedback

Behavioral

Personal feedback is given at the end of each automated telephone follow-up call, and reports back to the patient whether his och her symptom status is better, worse or equal, compared to the previous telephone call.

Interactive voice response without personal feedback

Behavioral

Control condition. Identical follow-up but without personal feedback.

Primary outcomes

  1. Retention in substance use disorder treatment

    Time frame: 3 months

    Duration of retention in treatment and whether the client remains in treatment at 3 months or not.

Secondary outcomes

  1. Improvement in substance use

    Time frame: 3 months

    Do patients in the intervention group improve more than in the control group, with respect to substance use (alcohol/drug use), during the duration of the interactive voice response intervention?

  2. Improvements in psychiatric symptoms

    Time frame: 3 months

    Do patients in the intervention group improve more than in the control group, with respect to psychiatric symptoms, during the duration of the interactive voice response intervention?

Other outcomes

  1. Clinical course with respect to emergency visits

    Time frame: 12 months

  2. Clinical course with respect to hospitalizations

    Time frame: 12 months

  3. Clinical course with respect to repeated treatment episodes

    Time frame: 12 months

Sponsors and collaborators

Lead sponsor

Region Skane

Other

Registry information

Official study title

A Randomized Controlled Trial of Interactive Voice Response With and Without Personal Feedback in the Treatment of Adolescents With Substance Use Disorders

Important dates

Study start
2012
Primary completion
2013
Study completion
2014
First posted
Oct 15, 2012
Registry last updated
Mar 16, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.